Buy now: Price action is in a clear uptrend (bullish MAs + expanding MACD) and Wall Street targets ($19.50–$21) imply additional upside from $18.59.
Momentum is strong but stretched (RSI-6 ~77.7), so near-term upside may be choppy; still, for an impatient buyer the trend and catalysts favor entry now.
SwingMax: Entry signal triggered on 2026-01-06; stock is +4.94% since, and trend structure remains constructive—still a usable continuation entry.
Sentiment checks: hedge funds neutral, insiders net selling (notable negative), no congress/politician activity provided.
Technical Analysis
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200 (trend-following signal remains positive).
Momentum: MACD histogram +0.0913 and expanding → upside momentum still building.
Overbought/extension: RSI_6 77.66 → stretched short-term; probability model also suggests slight near-term dip odds (next day/week).
Key levels: Pivot 17.856; Support 17.212 (S1); Resistance 18.897 (R2). Current 18.59 is above R1 (18.499), aiming toward R2.
Pattern-based forward view: Similar-pattern stats show ~+4.75% next month despite mild near-term softness.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Put/Call OI = 1.14 → slightly defensive/skewed to puts (cautious sentiment).
Volume: Put volume = 0 and total volume low (calls 9) but today vs 30D avg volume = 15.52x → activity spike off a small base.
Volatility: 30D IV ~40.89 vs HV ~24.91 → options pricing implies elevated forward uncertainty; IV rank 16.77 / IV percentile 37.45 (not extreme vs its own history).
Technical Summary
Sell
4
Buy
10
Positive Catalysts
Analyst support strengthened: multiple firms raised price targets (to $19.50, $20, $21) with Buy/Outperform/Overweight.
Capital return narrative: Truist cites expectations for increased buybacks in FY26.
Shareholder return: Declared $0.12 quarterly dividend (~2.75% yield), with near-term ex-date/record date catalyst (Feb 2).
Fundamentals (latest quarter 2025/Q4): Strong YoY growth in revenue, net income, and EPS supports the uptrend.
Neutral/Negative Catalysts
suggests some market participants are hedging.
Financial Performance
Latest quarter: 2025/Q4
Revenue: $452.0M, +22.17% YoY
Net Income: $168.7M, +53.36% YoY
EPS: $0.47, +56.67% YoY
Takeaway: Growth accelerated meaningfully YoY, reinforcing the bullish price trend and supporting analyst target increases.
Cons: some operating-line pressure flagged (NII/OpEx), which could slow upside if it persists.
Wall Street analysts forecast FNB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FNB is 19 USD with a low forecast of 18 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast FNB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FNB is 19 USD with a low forecast of 18 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 18.590
Low
18
Averages
19
High
20
Current: 18.590
Low
18
Averages
19
High
20
Truist
David Smith
Buy
maintain
$19
AI Analysis
2026-01-22
Reason
Truist
David Smith
Price Target
$19
AI Analysis
2026-01-22
maintain
Buy
Reason
Truist analyst David Smith raised the firm's price target on F.N.B. to $19.50 from $19 and keeps a Buy rating on the shares as part of a broader research note updating the firm's model on Capital Markets / Regional Banks names reporting results. The firm is citing its expectations for increased buybacks in FY26 while leaving its estimates unchanged, the analyst tells investors in a research note.
Keefe Bruyette
Kelly Motta
Outperform
maintain
$19 -> $20
2026-01-22
Reason
Keefe Bruyette
Kelly Motta
Price Target
$19 -> $20
2026-01-22
maintain
Outperform
Reason
Keefe Bruyette analyst Kelly Motta raised the firm's price target on F.N.B. to $20 from $19 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FNB
